We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-4 of 4

Proposed amendment would exempt some generic submissions from Canada’s PM(NOC) regulations

  • Torys LLP
  • -
  • Canada
  • -
  • October 4 2011

Health Canada has released a proposed amendment to its guidance document Patented Medicines (Notice of Compliance) Regulations

Federal Court of Canada grants data protection to an old medicinal ingredient

  • Torys LLP
  • -
  • Canada
  • -
  • February 14 2012

In a recent decision Celgene Inc. v. Canada (Minister of Health) the Federal Court of Canada declared that a drug containing a previously approved medicinal ingredient is nevertheless subject to data protection

Doing a deal with pharma

  • Torys LLP
  • -
  • Canada
  • -
  • August 4 2011

From the perspective of the biotech company, there are several legal and business issues to consider when doing a deal with big pharma

Health Canada’s guidance document on PM(NOC) Regulations now finalized

  • Torys LLP
  • -
  • Canada
  • -
  • April 4 2012

Health Canada has published an update to its guidance document on the application of the Patented Medicines (Notice of Compliance) Regulations